Conrad Fischer promotes carvedilol for portal hypertension, claiming large reductions in SBP, ascites requiring paracentesis, and death in patients with esophageal varices.
Carvedilol cuts risk of SBP by 50%
Carvedilol cuts risk of ascites needing paracentesis by 50%
Carvedilol cuts risk of DEATH by....75%!!!!!!!!!!!!!!!!!!!!
This finding is one of many signals tracked across Healthcare. The live feed updates every few hours with new expert voices, debates, and emerging ideas.
← Back to Healthcare